BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Reflow Medical received FDA de novo clearance for its Spur Peripheral Retrievable Stent System for infrapopliteal arterial ...

Add Medtronic to the growing list of companies and institutions rolling back the work-from-home movement that outlasted the ...

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

BioSig has merged with Streamex Exchange Corp. in a move that will take the British Columbia–based commodities tokenization ...

Camille Chang Gilmore, Boston Scientific’s global chief DEI officer announced she is leaving the company after two decades of ...

Dentsply Sirona this week announced it appointed Matthew Garth as EVP and chief financial officer, effective today.

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Abbott published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless pacemaker (LP) ...